Pharmacy study of natural health product adverse reactions (SONAR): a cross-sectional study using active surveillance in community pharmacies to detect adverse events associated with natural health products and assess causality
暂无分享,去创建一个
S. Vohra | H. Boon | R. Tsuyuki | R. Rosychuk | M. Ware | T. Charrois | J. Arnason | J. Barnes | B. Foster | M. Murty | D. Legatt | C. Necyk | G. Cembrowski
[1] Salvador Trinxet. Food and Drugs Act , 2015 .
[2] S. Vohra,et al. How well do pharmacists know their patients? A case report highlighting natural health product disclosure , 2013, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.
[3] E. Ernst,et al. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews , 2013, European Journal of Clinical Pharmacology.
[4] A. Alibrandi,et al. Attitudes and Opinion about Adverse Drug Events of Women Living in a City of South Italy , 2013, Pharmacology.
[5] W. Jaeger,et al. Study of Natural Health Product Adverse Reactions (SONAR): Active Surveillance of Adverse Events Following Concurrent Natural Health Product and Prescription Drug Use in Community Pharmacies , 2012, PloS one.
[6] D. Shaw,et al. Pharmacovigilance of herbal medicine. , 2012, Journal of ethnopharmacology.
[7] Neeraj Singhal,et al. The Effect of β-Carotene Supplementation on the Pharmacokinetics of Nelfinavir and Its Active Metabolite M8 in HIV-1-infected Patients , 2012, Molecules.
[8] G. Baker,et al. Reporting natural health product related adverse drug reactions: is it the pharmacist's responsibility? , 2011, The International journal of pharmacy practice.
[9] W. Jaeger,et al. Polypharmacy, multiple natural health products and hepatotoxicity , 2011, Canadian Medical Association Journal.
[10] P. Knapp,et al. Buyer beware? Does the information provided with herbal products available over the counter enable safe use? , 2011, BMC medicine.
[11] N. Craveiro,et al. Multiple drug exposure as a risk factor for the seriousness of adverse drug reactions. , 2011, Journal of nursing management.
[12] M. Williamson,et al. A national census of medicines use: a 24‐hour snapshot of Australians aged 50 years and older , 2011, The Medical journal of Australia.
[13] W. Jaeger,et al. Pharmacists' participation in research: a case of trying to find the time , 2010, The International journal of pharmacy practice.
[14] M. Gbéassor,et al. In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily. , 2010, Journal of ethnopharmacology.
[15] Humayoun Akhtar,et al. Food and therapeutic product interactions - a therapeutic perspective. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[16] M. Corazza,et al. Use of topical herbal remedies and cosmetics: a questionnaire‐based investigation in dermatology out‐patients , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[17] W. Jaeger,et al. A Tool for Rapid Identification of Potential Herbal Medicine—Drug Interactions , 2009 .
[18] S. Willich,et al. Educational intervention to improve physician reporting of adverse drug reactions (ADRs) in a primary care setting in complementary and alternative medicine , 2009, BMC public health.
[19] Barbara Bloom,et al. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. , 2009, National health statistics reports.
[20] G. Baker,et al. Adverse event reporting for herbal medicines: a result of market forces. , 2009, Healthcare policy = Politiques de sante.
[21] J. Arnason,et al. Comparative study of hop-containing products on human cytochrome p450-mediated metabolism. , 2009, Journal of agricultural and food chemistry.
[22] G. Farrell,et al. Hepatotoxic slimming aids and other herbal hepatotoxins , 2008, Journal of gastroenterology and hepatology.
[23] C. Xue,et al. Complementary and alternative medicine use in Australia: a national population-based survey. , 2007, Journal of alternative and complementary medicine.
[24] S. Vohra,et al. Community Identification of Natural Health Product–Drug Interactions , 2007, The Annals of pharmacotherapy.
[25] C. Cyr,et al. Use of Complementary and Alternative Medicine in a General Pediatric Clinic , 2007, Pediatrics.
[26] John R Horn,et al. Proposal for a New Tool to Evaluate Drug Interaction Cases , 2007, The Annals of pharmacotherapy.
[27] D. Johnston. Natural standard herb and supplement reference: evidence based clinical reviews , 2006, The Ulster medical journal.
[28] K. Shields. Natural Standard Herb & Supplement Reference: Evidence-Based Clinical Reviews , 2006 .
[29] J. Grzywacz,et al. Use of complementary and alternative medicine by persons with arthritis: results of the National Health Interview Survey. , 2005, Arthritis and rheumatism.
[30] C. Sherbourne,et al. Use of herbal medicine in primary care patients with mood and anxiety disorders. , 2005, Psychosomatics.
[31] L. de Jong-van den Berg,et al. Pharmacists' role in reporting adverse drug reactions in an international perspective , 2004, Pharmacoepidemiology and drug safety.
[32] J. Cox,et al. Use of complementary and alternative medical therapies in patients with cardiovascular disease. , 2003, American heart journal.
[33] Luigi Cantarutti,et al. Active monitoring of adverse drug reactions in children , 2000, The Lancet.
[34] W. Inman,et al. Under-reporting of adverse drug reactions. , 1985, British medical journal.
[35] D. Greenblatt,et al. A method for estimating the probability of adverse drug reactions , 1981, Clinical pharmacology and therapeutics.
[36] J. Roberts. Expanding role for pharmacists , 1978, British medical journal.
[37] Emmanouel A. Varvarigos,et al. Survey , 2016, ACM Comput. Surv..
[38] J. Arnason,et al. Comparative study of hops-containing products on human cytochrome P450-mediated metabolism. , 2011, Journal of agricultural and food chemistry.
[39] S. Vohra,et al. Potential Vitamin-Drug Interactions in Children , 2009, Paediatric drugs.
[40] Masuhiro Kogoma. 総論;総論;Introduction , 2006 .